CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $247,000 | -19.5% | 110,614 | -10.2% | 0.25% | -11.5% |
| Q2 2022 | $307,000 | -43.5% | 123,148 | +10.7% | 0.28% | -25.1% |
| Q1 2022 | $543,000 | -23.0% | 111,259 | +78.6% | 0.37% | -19.9% |
| Q4 2021 | $705,000 | -6.5% | 62,295 | +20.3% | 0.46% | -3.5% |
| Q3 2021 | $754,000 | +34.9% | 51,766 | +8.0% | 0.48% | +34.5% |
| Q2 2021 | $559,000 | +7.3% | 47,953 | +12.3% | 0.36% | +1.1% |
| Q1 2021 | $521,000 | -25.7% | 42,702 | -23.8% | 0.35% | -24.2% |
| Q4 2020 | $701,000 | – | 56,035 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |